ArticleJournal of Cancer2010
Tumor cell budding from focally disrupted tumor capsules: a common pathway for all breast cancer subtype derived invasion?
Article in Journal of Cancer, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 24 citations in OpenAlex.
- Involvement ofFrontiers in cell and developmental biology · 2024Article
- Geometric tumor embolic budding characterizes inflammatory breast cancer.Breast cancer research and treatment · 2023Article
- The most likely but largely ignored triggering factor for breast (or all) cancer invasion.Journal of Cancer · 2023Article
- Article
- Prognostic role of tumor budding in breast cancer.World journal of experimental medicine · 2018Article
- Animal models for studying tumor microenvironment (TME) and resistance to lymphocytic infiltration.Cancer biology & therapy · 2018Review
- The cell surface mucin podocalyxin regulates collective breast tumor budding.Breast cancer research : BCR · 2016Article
- The "cavitary" type of angiogenesis by gastric cancer. Morphological characteristics and prognostic value.Journal of Cancer · 2014Article
- Cell budding from normal appearing epithelia: a predictor of colorectal cancer metastasis?International journal of biological sciences · 2013Article
- Tumor-infiltrating immune cells promoting tumor invasion and metastasis: existing theories.Journal of Cancer · 2013Article
- Tumor-infiltrating immune cells: triggers for tumor capsule disruption and tumor progression?International journal of medical sciences · 2013Article
- Tube-like structures with co-expression of D2-40 and CD34: newly formed vasculatures?International journal of biological sciences · 2012Article
- The myoepithelial cell layer may serve as a potential trigger factor for different outcomes of stage-matched invasive lobular and ductal breast cancers.International journal of biological sciences · 2011Article
- Putative biomarkers and targets of estrogen receptor negative human breast cancer.International journal of molecular sciences · 2011Review
- Malignant transformation and stromal invasion from normal or hyperplastic tissues: true or false?Journal of Cancer · 2011Article
- Metastasis Update: Human Prostate Carcinoma Invasion via Tubulogenesis.Prostate cancer · 2011Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Human breast cancer represents a group of highly heterogeneous lesions consisting of about 20 morphologically and immnohistochemically distinct subtypes with substantially different prognoses. Our recent studies have suggested that all breast cancer subtypes, however, may share a common pathway, tumor cell budding from focally disrupted tumor capsules, for their invasion. The potential mechanisms and clinical implications of our observations are discussed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.